Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...
Daimler Truck Holding AG ( DTRUY) Q4 2025 Earnings Call March 12, 2026 4:00 AM EDT Good morning, everyone, and welcome to the 2025 Annual Results Conference of Daimler Truck. Thank you for joining us.
This is an audio transcript of The Economics Show podcast episode: ‘Is AI (finally) making us more productive? With John Burn-Murdoch and Sarah O’Connor’ Soumaya Keynes I have read a lot of science ...
A comparative evaluation indicates that climate anomalies over the past three years have been particularly severe. The rise in temperatures in certain regions, alongside unprecedented climate ...
The debut of Credor at Watches and Wonders marks a major milestone in the international expansion of Seiko Watch Corporation's most discreet luxury brand. In this interview with Europa Star, Akio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results